Cetuximab plus radiotherapy in patients with unresectable locally advanced squamous cell carcinoma of head and neck region - A open labelled single arm phase II study.

Dattatreya, S; Goswami, C

Dattatreya, S; Goswami, C.

Indian J Cancer ; 2011 Apr-Jun; 48(2): 154-157

Article in En | IMSEAR | ID: sea-144444

Subject(s)

Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal/therapeutic use; Antineoplastic Agents/therapeutic use; Brachytherapy; Carcinoma, Squamous Cell/pathology; Carcinoma, Squamous Cell/therapy; Chemoradiotherapy; Disease Progression; Feasibility Studies; Head and Neck Neoplasms/pathology; Head and Neck Neoplasms/therapy; Humans; Male; Middle Aged; Survival Rate; Time Factors; Treatment Outcome; Young Adult

Key words

Concomitant; monoclonal antibody; squamous cell carcinoma of the head and neck

Fulltext

Add to My VHL

XML

Search on Google

Full text: 1 Index: IMSEAR Main subject: Time Factors / Aged, 80 and over / Brachytherapy / Aged / Humans / Male / Carcinoma, Squamous Cell / Feasibility Studies / Survival Rate / Treatment Outcome Limits: Aged80 Language: En Journal: Indian J Cancer Year: 2011 Type: Article

Fulltext

Add to My VHL

XML

Search on Google